申请人:Gil Santano Joan
公开号:US20130190367A1
公开(公告)日:2013-07-25
Compounds of formula (I) or their pharmaceutically acceptable salts, or their stereoisomers or mixtures of stereoisomers, where: R
1
is selected from the group consisting of: phenyl, and phenyl mono-, di-, or tri-substituted by a radical independently selected from the group consisting of F, Cl, Br, I, (C
1
-C
6
)-alkyl, COO-(C
1
-C
6
)-alkyl, and (C
1
-C
6
)-alkoxy; and R
2
is a radical selected from the same group as R
1
, further including a phenyl substituted in 4-position by a radical independently selected from the group consisting of —O(CH
2
)CONH(CH
2
)
3
CH
3
and OCH
2
COOC(CH
3
)
3
, a biphenyl-4-yl, thiazol-2-yl, and a thiazol-2-yl mono- or di-substituted by a radical selected from F and phenyl; inhibit cell proliferation of tumor cells independently of p53 protein and may also induce apoptosis in several tumor cells independently of p53 protein, being useful for the treatment of several types of cancer.
式(I)的化合物或其药学上可接受的盐,或其立体异构体或立体异构体混合物,其中:R1选自以下群组:苯基,以及苯基单、双、或三位上由以下基团中独立选择的基团取代:F、Cl、Br、I、(C1-C6)-烷基、COO-(C1-C6)-烷基和(C1-C6)-烷氧基;而R2是从与R1相同的群组中选择的基团,还包括在4位上由以下基团中独立选择的基团取代的苯基:—O(CH2)CONH(CH2)3CH3和OCH2COOC(CH3)3,联苯基-4-基、噻唑-2-基和噻唑-2-基单或双取代的基团中选择F和苯基的化合物,独立于p53蛋白质抑制肿瘤细胞增殖,也可能在几种独立于p53蛋白质的肿瘤细胞中诱导凋亡,可用于治疗多种类型的癌症。